Viewing Study NCT05962502


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2026-05-30 @ 4:30 AM
Study NCT ID: NCT05962502
Status: RECRUITING
Last Update Posted: 2023-08-31
First Post: 2023-07-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cetuximab Plus Irinotecan in Patients With NeoRAS Wild-type Metastatic Colorectal Cancer In Third-line Therapy
Sponsor: Sun Yat-sen University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None NeoRAS wild-type View
None mCRC View
None Cetuximab View
None Third-line therapy View